Bile acids and lipoprotein metabolism: A renaissance for bile acids in the post-statin era?

Current Opinion in Lipidology

Volumn 10, Issue 3, 1999, Pages 269-274

  Angelin, Bo ^a,b   Eriksson, Mats ^a   Rudling, Mats ^a  

^a Ctr for Metab and Endocrinology   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; APOLIPOPROTEIN A1; BILE ACID; CHENODEOXYCHOLIC ACID; CHOLESTEROL; CHOLESTEROL 7ALPHA MONOOXYGENASE; COLESTYRAMINE; GROWTH HORMONE; HIGH DENSITY LIPOPROTEIN; HYPOCHOLESTEROLEMIC AGENT; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PRODRUG; RESIN; STATIN;

ATHEROSCLEROSIS; BILE ACID METABOLISM; BILE ACID SYNTHESIS; CHOLESTEROL METABOLISM; CLINICAL TRIAL; DRUG RESEARCH; ENTEROHEPATIC CIRCULATION; GENE THERAPY; HUMAN; HYPERCHOLESTEROLEMIA; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; LIVER METABOLISM; MALABSORPTION; NONHUMAN; PRIORITY JOURNAL; REVIEW;

AGING; ANIMALS; BILE ACIDS AND SALTS; CHOLESTEROL; CHOLESTEROL 7-ALPHA-HYDROXYLASE; ENTEROHEPATIC CIRCULATION; ENZYME ACTIVATION; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; LIPOPROTEINS; MALABSORPTION SYNDROMES;

EID: 0032816659     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-199906000-00009     Document Type: Review

References (51)

1. 1 Angelin B, Einarsson K. Bile acids and lipoprotein metabolism. Atheroscler Rev 1986; 15:41-66.
2. 2 Vlahcevic ZR, Heuman DM, Hylemon PB. Regulation of bile acid synthesis. Hepatology 1991; 13:590-600.
3. 3 Dietschy JM, Turley SD, Spady DK. Role of liver in the maintenance of cholesterol and low density lipoprotein homeostasis in different animal species, including humans. J Lipid Res 1993; 34:1637-1659.
4. 4 Angelin B. Studies on the regulation of hepatic cholesterol metabolism in humans. (Mack-Forster Award Lecture). Eur J Clin Invest 1995; 25:215-224.
5. 5 Princen HMG, Post SM, Twisk J. Regulation of bile acid biosynthesis. Curr Pharmaceut Design 1997; 3:59-84.
6. 6 Brown MS, Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science 1986; 232:34-47.
7. 7 Dawson PA, Oelkers P. Bile acid transporters. Curr Opin Lipidol 1995; 6:109-114.
8. 8 Rigotti A, Trigatti B, Babitt J, Penman M, Xu SH, Krieger M. Scavenger receptor Bl - a cell surface receptor for high density lipoprotein. Curr Opin Lipidol 1997; 8:181-188.
9. 9 Schwarz M, Lund EG, Russell DW. Two 7α-hydroxylase enzymes in bile acid biosynthesis. Curr Opin Lipidol 1998; 9:113-118.
10. 10 Love MW, Dawson PA. New insights into bile acid transport. Curr Opin Lipidol 1998; 9:235-229.
11. 11 Edwards PA, Ericsson J. Signaling molecules derived from the cholesterol biosynthetic pathway: mechanisms of action and possible roles in human disease. Curr Opin Lipidol 1998; 9:433-440.
12. 12 deRoos B, Katan MB. Possible mechanisms underlying the cholesterol-raising effect of the coffee diterpene cafesterol. Curr Opin Lipidol 1999; 10:41-45.
13. 13 Björkhem I, Diczfalusy U, Lütjohann D. Removal of cholesterol from extrahepatic sources by oxidation mechanisms. Curr Opin Lipidol 1999, 10:161-165.
14. 14 Hillebrant CG, Nyberg B, Einarsson K, Eriksson M. The effect of plasma low density lipoprotein apheresis on the hepatic secretion of biliary lipids in humans. Gut 1997; 41:700-704.
15. 15 Kozarsky KF, Donahee MH, Rigotti A, Iqbal SN, Edeiman ER, Krieger M. Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels. Nature 1997; 387:414-417.
16. 16 Sehayek E, Ono JE, Shefer S, Nguyen LB, Wang N, Batta AK, et al. Biliary cholesterol excretion: a novel mechanism that regulates dietary cholesterol absorption. Proc Natl Acad Sci USA 1998; 95:10194-10199.
17. 17 Rigotti A, Trigatti BL, Penman M, Rayburn H, Herz J, Krieger M. A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism. Proc Natl Acad Sci USA 1997, 94:12610-12615.
18. 18 Connelly MA, Klein SM, Azhar S, Abumrad NA, Williams DL. Comparison of class B scavenger receptors, CD36 and scavenger receptor BI (SR-BI), shows that both receptors mediate high density lipoprotein-cholesteryl ester selective uptake but SR-BI exhibits a unique enhancement of cholesteryl ester uptake. J Biol Chem 1999; 274:41-47.
19. 19 Murao K, Terpstra V, Green SR, Kondratenko N, Steinberg D, Ouehenberger O. Characterization of CLA-1, a human homologue of rodent scavenger receptor B I, as a receptor for high density lipoprotein and apoptotic thymocytes. J Biol Chem 1997; 272:17551-17557.
20. 20 Tall AR, Breslow JL: Plasma high-density lipoproteins and atherogenesis. In: Atherosclerosis and coronary artery disease. Fuster V, Ross R, Topol E (editors). Philadelphia: Lippincott-Raven; 1996: pp105-128.
21. 21 Eriksson M, Carlson LA, Miettinen TA, Angelin B. Stimulation of fecal steroid excretion after infusion of recombinant proapolipoprotein A-1: potential reverse cholesterol transport in man. Circulation 1999 (in press).
22. 22 Björkhem I. Mechanism of bite acid biosynthesis in mammalian liver. In: Sterols and bile acids. Danielsson H, Sjövall J (editors). Amsterdam: Elsevier; 1985; 12:231-278.
23. 23 Russell DW, Setchell KDR: Bile acid biosynthesis. Biochemistry 1992; 31:4737-4749.
24. 24 Ishibashi S, Schwarz M, Frykman PK, Herz J, Russell DW. Disruption of cholesterol 7α-hydroxylase gene in mice. I. Postnatal lethality reversed by bile acid and vitamin supplementation. J Biol Chem 1996; 271:18017-18023.
25. 25 Schwarz M, Lund EG, Setchell KDR, Kayden HJ, Zerwekh JE, Björkhem I, et al. Disruption of cholesterol 7α-hydroxylase gene in mice. II. Bile acid deficiency is overcome by induction of oxysterol 7α-hydroxylase. J Biol Chem 1996; 271:18024-18031.
26. 26 Schwarz M, Lund EG, Lathe R, Björkhem I, Russell DW. Identification and characterization of a mouse oxysterol 7α-hydroxylase cDNA. J Biol Chem 1997; 272:23995-24001.
27. 27 Rosen H, Reshef A, Maeda N, Lippoldt A, Shpizen S, Triger L, et al. Markedly reduced bile acid synthesis but maintained levels of cholesterol and vitamin D metabolites in mice with disrupted sterol 27-hydroxylase gene. J Biol Chem 1998; 273:14805-14812.
28. 28 Rudling M, Angelin B, Stähle L, Reihnér E, Sahlin S, Olivecrona H, et al. Cholesterol homeostasis in human liver: coordinate control of messenger mRNA levels of key regulatory proteins. Submitted for publication. 1999.
29. 29 Lehmann JM, Kliewer SA, Moore LB, Smith-Oliver TA, Oliver BB, Su JL, et al. Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. J Biol Chem 1997; 272:3137-3140.
30. 30 Peet DJ, Turley SD, Ma W, Janowski BA, Lobaccaro J-MA, Hammer RE, Mangelsdorf DJ. Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXRa. Cell 1998; 93:693-704.
31. 31 Cohen JC, Cali JJ, Jelinek DF, Mehrabian M, Sparkes RS, Lusis AJ, et al. Cloning of the human cholesterol 7α-hydroxylase gene (C4P7) and localization to chromosome Bq 11 -q 12. Genomics 1992; 14:153-161.
32. 32 Wang J, Freeman DJ, Grundy SM, Levine DM, Guerra R, Cohen JC. Linkage between cholesterol 7α-hydroxylase and high plasma low-density lipoprotein cholesterol concentrations. J Clin Invest 1998, 101:1283-1291.
33. 33 Spady DK, Cuthbert JA, Willard MM, Meidell RS. Adenovirus-mediated transfer of a gene encoding cholesterol 7α-hydroxylase into hamsters increases hepatic enzyme activity and reduces plasma total and low density lipoprotein cholesterol. J Clin Invest 1995, 96:700-709.
34. 34 Spady DK, Cuthbert JA, Willard MN, Meidell RS. Overexpression of cholesterol 7α-hydroxylase (CYP7A) in mice lacking the low density lipoprotein (LDL) receptor gene. J Biol Chem 1998; 273:126-132.
35. 35 Deckelbaum RJ, Lees RS, Small DM, Hedberg SE, Grundy SM. Failure of complete biliary diversion and oral bile acid therapy in the treatment of homozygous familial hypercholesterolemia. N Engl J Med 1977; 296:465-470.
36. 36 Mol JM, Stalenhoef AF, Demacker PN, van't Laar A. Low-density lipoprotein catabolism in WHHL rabbits after partial ileal bypass surgery. Biochim Biophys Acta 1989; 1003:167-174.
37. 37 Ericsson S, Berglund L, Frostegârd J, Einarsson K, Angelin B. The influence of age on low density lipoprotein metabolism: effects of cholestyramine treatment in young and old healthy male subjects. J Intern Med 1997; 242:329-337.
38. 38 Rudling M, Parini P, Angelin B. Growth hormone and bile acid synthesis. Key role for the activity of hepatic microsomal cholesterol 7α-hydroxylase in the rat. J Clin Invest 1997; 99:2239-2245.
39. 39 Rudling M, Angelin B. Loss of resistance to dietary cholesterol in the rat after hypophysectomy: importance of the presence of growth hormone for hepatic low density lipoprotein-receptor expression. Proc Nat Acad Sci U S A 1993; 90:8851-8855.
40. 40 Angelin B, Rudling M: Growth hormone and hepatic lipoprotein metabolism. Curr Opin Lipidol 1994; 5:157-159.
41. 41 Rudling M, Norstedt G, Olivecrona H, Reihner E, Gustafsson JA, Angelin B. Importance of growth hormone for the induction of hepatic low density lipoprotein receptors. Proc Nat Acad Sci U S A 1992; 89:6983-6987.
42. 42 Olivecrona H, Ericsson S, Angelin B. Growth hormone treatment does not alter biliary lipid metabolism in healthy adult men. J Clin Endocrinol Metab 1995; 80:1113-1117.
43. 43 Parini P, Angelin B, Rudling M. Cholesterol and lipoprotein metabolism in aging: reversal of hypercholesterolemia by growth hormone treatment in old rats. Arterioscler Thromb Vasc Biol 1999, 19:832-839.
44. 44 Carey MC. The enterohepatic circulation. In: The liver: biology and pathology. Arias I, Popper H, Schachter D, Shafritz DA (editors). New York: Raven Press; 1982, 429-465.
45. 45 Higaki J, Hara S, Takasu N, Tonda K, Miyata K, Shike T, et al. Inhibition of ileal Nat/bile acid cotransporter by S-8921 reduces serum cholesterol and prevents atherosclerosis in rabbits. Arterioscler Thromb Vasc Biol 1998; 18:1304-1311.
46. 46 Oelkers P, Kirby LC, Heubi JE, Dawson PA. Primary bile acid malabsorption caused by mutations in the ileal sodium-dependent bile acid transporter gene (SLC 10A2). J Clin Invest 1997; 99:1880-1887.
47. 47 Thaysen EH, Pedersen L. Idiopathic bile acid catharsis. Gut 1976; :965-970.
48. 48 Angelin B, Hershon KS, Brunzell JD. Bile acid metabolism in hereditary forms of hypertriglyceridemia: evidence for an increased synthesis rate in monogenic familial hypertriglyceridemia. Proc Nat Acad Sci U S A 1987, 84:5434-5438.
49. 49 Duane WC. Abnormal bile acid absorption in familial hypertriglyceridemia. J Lipid Res 1995; 36:96-107.
50. 50 Shoda J, Miyamoto J, Kano M, Ikegami T, Matsuraki Y, Tanaka N, et al. Simultaneous determination of plasma mevalonate and 7α-hydroxy-4-cholosten-3-one levels in hyperlipoproteinemia: convenient indices for estimating hepatic defects of cholesterol and bile acid synthesis and biliary cholesterol. Hepatology 1997; 25:18-26.
51. 51 Angelin B, Ericsson S, Leijd B, Berglund L, Einarsson C. Familial hypertriglyceridemia with bile absorption: defective intestinal absorption of bile acids leading to increased clearance of plasma low density lipoproteins. Submitted for publication. 1999.